Page 231 - bandung_Neat

According to Bio Farma, BPOM has obtained positive results from the clinical trial
stages of the COVID-19 vaccine, comprising the pre-clinical trials, phase 1 clinical
trials, and phase 2 clinical trials conducted in China.

Bio Farma has partnered with Sinovac owing to a similar platform between the
vaccine developed by Sinovac and Bio Farma's ability to produce it, specifically the
inactivated vaccine.

The Faculty of Medicine University of Padjajaran and Bio Farma recruited 1,620
volunteers after undergoing two stages of selection, with 540 people in the first
stage, and 1,080 volunteers in the second.

Volunteers were selected after clearing the test for immunogenicity, or immune
response, and efficacy, or response against viruses, through blood tests.

The vaccine administration will be conducted in stages, with the first wave during the
second week of August for 120 volunteers. The next test will be held in the third and
fourth week of August, for each of the 144 volunteers, so by early September, as
many as 408 volunteers are estimated to have undergone vaccine tests.

This process will be conducted continuously on 1,620 volunteers and will last until
the third week of December. Most volunteers are the residents of Bandung, as they
need to be subject to continuous checks and undergo routine analysis in gauging the
effectiveness of the vaccine.

Thohir also expressed Bio Farma's readiness to boost production capacity by
utilizing existing production facilities on its land, thereby circumventing the need for
additional investments.

Bio Farma is pegged to be able to produce a maximum of 100 million vaccines by
December 2020.

"Bio Farma is ready to increase its production capacity by 150 million doses to reach
250 million doses," President Director of Bio Farma Honesti Basyir stated.